DocDollars

Tris Pharma Inc

NJ · United States · Reporting entity ID 100000011232

Total reported 2019–2025
$25.8M
#268 of 2,960 reporting companies — 0% of all reported industry payments
$5.48M in general payments across 129,049 records, plus $20.3M in research funding across 252 records.

How it breaks down

General payments $5,483,171
Research funding $20,322,168

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Tris Pharma Inc reported $25.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #268 of 2,960 reporting companies. 79% of that was research funding and 21% general payments such as consulting, speaking, food and travel. 129,049 general payment records and 252 research records were filed.

Common questions about Tris Pharma Inc

How much has Tris Pharma Inc paid US doctors?

Tris Pharma Inc reported $25,805,339 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $5,483,171 in general payments, $20,322,168 in research funding.

How does Tris Pharma Inc rank among drug and device companies?

It ranks #268 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Tris Pharma Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.